摘要
早发现、早诊断是治愈肿瘤的关键。随着分子生物学技术的不断发展，肿瘤标志物检测在原发性肿瘤的发现、高危人群的筛查及肿瘤的发生发展等方面发挥着越来越重要的作用。目前临床上用于早期诊断、指导治疗及预后评估的成熟的肿瘤标志物相对有限，这些肿瘤标志物在临床应用上均存在一定的优势与局限性。而细胞增殖类标志物有望提高肿瘤的诊断检出率。
Early detection and diagnosis are the key steps in curing tumors .With the development of molecular biology technology , tumor biomarkers detection plays an increasingly important role in many aspects, such as looking for primary tumors , screening tumor susceptible persons and estimating the progression of various tumors .The number of frequently used tumor biomarkers in early detection , guiding treatment and estimating prognosis is limited .All these tumor biomarkers show their own advantages and certain limitations in clinical application .The tumor markers used in targeting cell proliferation are hopeful in promoting the rate of tumor detection .
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2016年第12期995-998,共4页
Chinese Journal of Laboratory Medicine
关键词
肿瘤标志物
早期诊断
细胞增殖
Tumor biomarker
Early detection
Cell proliferation
作者简介
通信作者：李林海，电子信箱：mature303@126．com
